The experimental study of Bezafibrate on caspase-3 expression of βcell in type 2 diabetic rats

Cai Xia,Lai Xiaoyang,Zhang Li
DOI: https://doi.org/10.3969/j.issn.1006-2238.2010.05.005
2010-01-01
Abstract:Objective To observe the effect of Bezafibrate on caspase-3 expression of βcell in type-2 diabetic rats and the mechanism of protection toβcell.Methods We adopted injecting Sprague-Dawley rats with low dose STZ after high calorie to make type 2 diabetes.28 type 2 diabetes models were formed,there were divided into diabetes rats with bezafibrate group(DMB,n=14) and Diabetes group(DM,n=14).Normalgroup(NC,n=14)were included,DMB group were treated with bezafibrate(50mg/kg) everday,DM and NC group were given the same dose of distilled water.The levels of Triglyceride(TG),Total cholesterol(TC),Fasting blood glucose(FBG),Fasting insulins(FINs) were detected before and after the treatment of bezafibrate respectively.After 12 weeks intervention.Pancreas were dyed with Hematoxylin-Eosin,the morphous of pancreas islet were observed by microscope,the apoptosis of cells was detected by TUNEL,the expression of caspase-3 in islets of rats was detected by immunohistochemistry.Results(1)The levels of TG,TC were decreased conspicuously in DMB groups after intervention(P<0.01),the levels of FBG was also decreased,the levels of FINS was increased(P<0.05);(2)The apoptosis index ofβ-cells and expression of caspase-3 was decreased in DMB group(P<0.05).Conclusion Intervening hyperlipemia with Bezafibrate could reduce the resistance of iusulin and improve the secretary function of βcell,was associated with decreasing expression of caspase-3 and apoptosis of βcell to the protection of βcell.
What problem does this paper attempt to address?